Citation: Ps. Spencer, Mechanisms of selective toxicity in neurodegenerative disorders, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 1-16
Citation: A. Storch et J. Schwarz, The dopamine transporter: Involvement in selective dopaminergic neurodegeneration, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 17-40
Citation: S. Przedborski, Advances in our knowledge of MPTP action and mechanism, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 41-53
Citation: G. Cappelletti et al., Role of microtubules in the genesis of MPTP neurotoxicity, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 55-58
Citation: R. Ortmann et al., Complex I inhibition in cultured cells as model for Parkinson's disease, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 59-63
Authors:
Scherfler, C
Seppi, K
Puschban, Z
Weiler, B
Granbichler, H
Poewe, W
Wenning, GK
Citation: C. Scherfler et al., Nigral degeneration in animal models of multiple system atrophy, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 65-68
Authors:
Naoi, M
Maruyama, W
Akako, Y
Nakagawa, Y
Takahashi, T
Citation: M. Naoi et al., Apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol: Relevance toParkinson's disease, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 77-89
Authors:
Musshoff, F
Schmidt, P
Dettmeyer, R
Priemer, F
Wittig, H
Madea, B
Citation: F. Musshoff et al., Systematic studies of dopamine and dopamine-derived salsolinol and norsalsolinol levels in various human brain areas, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 101-104
Authors:
Antkiewicz-Michaluk, L
Romanska, I
Michaluk, J
Citation: L. Antkiewicz-michaluk et al., Antidopaminergic effects of putative endogenous MPTP-like agents: 1,2,3,4-tetrahydroisoquinoline and 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 105-110
Citation: P. Pagel et al., Development of an HPLC-method and synthesis of 1,2,3,4-tetrahydroisoquinolines as reference compounds for the identification of possible neurotoxins in the blood of Parkinson's disease patients, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 111-114
Citation: Ma. Collins et Ej. Neafsey, beta-carboline analogues of MPP+ as environmental neurotoxins, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 115-130
Citation: K. Matsubara, N-methyl-beta-carbolinium neurotoxins in Parkinson's disease, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 131-143
Authors:
Bringmann, G
Bruckner, R
Munchbach, M
Feineis, D
God, R
Wesemann, W
Grote, C
Herderich, M
Diem, S
Lesch, KP
Mossner, R
Storch, A
Citation: G. Bringmann et al., 'TaClo', a chloral-derived mammalian alkaloid with neurotoxic properties, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 145-149
Citation: S. Diem et al., Nutritional sources of novel tetrahydro-beta-carbolines, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 151-154
Citation: Tj. Montine et al., Endogenous brain catechol thioethers in dopaminergic neurodegeneration, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 155-166
Authors:
Burke, WJ
Li, SW
Schmitt, CA
Zahm, DS
Chung, HD
Conway, AD
Lampe, P
Johnson, EM
Lin, TS
Kristal, BS
Barg, J
Anwar, M
Ruggiero, DA
Citation: Wj. Burke et al., Catecholamine-derived aldehyde neurotoxins, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 167-180
Authors:
Dryhurst, G
Shen, XM
Li, H
Yang, ZL
Han, JL
Cheng, FC
Citation: G. Dryhurst et al., Potential roles of accelerated dopamine oxidation, altered glutathione metabolism, 5-S-cysteinyl-dopamine and its oxidative metabolites in the pathogenesis of Parkinson's disease, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 181-209
Authors:
Double, KL
Zecca, L
Ben-Shachar, D
Youdim, MBH
Riederer, P
Gerlach, M
Citation: Kl. Double et al., Neuromelanin may mediate neurotoxicity via its interaction with redox active iron, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 211-218
Authors:
Dodel, RC
Bales, KR
Bender, M
Nunez, G
Hyslop, P
Oertel, WH
Paul, SM
Du, YS
Citation: Rc. Dodel et al., bcl-2 protects SK-N-SH cells from 6-hydroxydopamine induced apoptosis by inhibition of cytochrome c redistribution, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 219-231
Citation: A. Pezzella et G. Prota, Generation of neurotoxins by new reaction pathways of dopamine under oxidative stress conditions: Contributing etiopathological factors in Parkinson's disease, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 233-236
Authors:
Song, S
Cardozo-Pelaez, F
Sanchez-Ramos, J
Citation: S. Song et al., Relationship of organochlorine pesticides to Parkinsonism, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 237-245
Citation: Ay. Sun et Xw. Li, Paraquat is a model environmental neurotoxin for studying Parkinson's disease, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 247-257
Citation: M. Gerlach et al., Brain iron and other trace metals in neurodegenerative diseases, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 259-276